{"query": "Dr Reddys Share Price Highlights: Dr. Reddys Stock Price History", "similar": [{"title": "Appetite increases for pharma stocks", "date": "2021-04-14 00:39:44.000", "impact": "+2.48%"}, {"title": "Auto, pharma stocks offering margin of safety top funds’ buy list in July", "date": "2023-08-14 07:52:00", "impact": "+0.76%"}, {"title": "Nazara Technologies, BPCL, Biocon in focus", "date": "2021-03-30 08:40:00.000", "impact": "+3.56%"}]}
{"query": "Stocks in news: RIL, PC Jeweller, Dr Reddy's, Enviro Infra Engineers, HDFC Life, SBI Life", "similar": [{"title": "Bharti Airtel, RIL, Vodafone idea, SBI, ZEEL, Srei Infra Finance, Cadila Healthcare stocks in focus", "date": "2021-10-06 08:49:18.000", "impact": "-2.14%"}, {"title": "RIL, SBI, Infosys, Bharti Airtel, Nazara Tech, Zee Entertainment, Tata Steel, Titan, textile stocks in focus", "date": "2021-10-07 08:15:23.000", "impact": "-2.14%"}, {"title": "Key Stocks in Focus Today: HDFC, Tata Motors, Bajaj Consumer, Natco Pharma & More", "date": "2022-12-06 05:30:00.000", "impact": "-2.71%"}]}
{"query": "Dr. Reddy's up 2% on launching Toripalimab to treat nasopharyngeal cancer", "similar": [{"title": "Dr Reddy’s Lab spurts after DGCI nod for single-shot Sputnik Light vaccine", "date": "2022-02-07 10:00:00", "impact": "+0.13%"}, {"title": "Why stock market experts are bullish on Dr. Reddy’s shares? Key levels to watch", "date": "2021-09-06 14:07:22", "impact": "-0.57%"}, {"title": "Dr Reddys Lab climbs after US court dismisses claims against generic Revlimid", "date": "2022-12-29 09:50:22", "impact": "-2.18%"}]}
{"query": "Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma", "similar": [{"title": "Dr Reddy’s becomes the first Indian company to launch an anti-cancer drug in China", "date": "2021-10-14 17:30:00", "impact": "+1.82%"}, {"title": "Apollo Hospitals to offer antibody cocktail to treat mild Covid-19 cases", "date": "2021-05-28 14:28:57.000", "impact": "-0.79%"}, {"title": "Diabetes drug Januvia’s patent protection ends; more generic versions coming soon", "date": "2022-07-08 08:31:00.000", "impact": "+1.01%"}]}
{"query": "Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market", "similar": [{"title": "BRIEF-Dr.Reddy’s Labs Launces Capecitabine Tablets, USP In U.S. Market By Reuters", "date": "2021-02-17 10:54:05", "impact": "-2.31%"}, {"title": "Dr Reddy’s re-launches Naproxen Sodium OTC Tablets in US market", "date": "2021-08-04 08:42:00", "impact": "+1.00%"}, {"title": "Dr Reddy’s Lab launches Fluphenazine Tablets in US", "date": "2021-02-18 10:54:00", "impact": "-2.31%"}]}
{"query": "Dr Reddy's launches Toripalimab to treat nasopharyngeal cancer in India", "similar": [{"title": "Dr Reddy’s becomes the first Indian company to launch an anti-cancer drug in China", "date": "2021-10-14 17:30:00", "impact": "+1.82%"}, {"title": "CSIR-IICT, Bengaluru pharma firm join hands to make Covid drug 2-DG", "date": "2021-06-15 18:01:00", "impact": "-3.10%"}, {"title": "Diabetes drug Januvia’s patent protection ends; more generic versions coming soon", "date": "2022-07-08 08:31:00.000", "impact": "+1.01%"}]}
{"query": "Dr. Reddy’s launches Toripalimab to treat rare cancer, India 3rd country to access the drug", "similar": [{"title": "Dr Reddy’s becomes the first Indian company to launch an anti-cancer drug in China", "date": "2021-10-14 17:30:00", "impact": "+1.82%"}, {"title": "CSIR-IICT, Bengaluru pharma firm join hands to make Covid drug 2-DG", "date": "2021-06-15 18:01:00", "impact": "-3.10%"}, {"title": "Why stock market experts are bullish on Dr. Reddy’s shares? Key levels to watch", "date": "2021-09-06 14:07:22", "impact": "-0.57%"}]}
{"query": "Pharma stock in focus after it launches India’s first neck & head cancer treatment drug", "similar": [{"title": "Dr Reddy’s becomes the first Indian company to launch an anti-cancer drug in China", "date": "2021-10-14 17:30:00", "impact": "+1.82%"}, {"title": "Sun Pharma rises as arm launches breast cancer drug", "date": "2023-01-11 10:50:17.000", "impact": "+0.63%"}, {"title": "Sun Pharma: Sustained Traction In Speciality To Be A Re-rating Driver", "date": "2021-01-31 01:22:13.000", "impact": "-8.71%"}]}
